Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma